Trimeric Tn antigen on syndecan 1 produced by ppGalNAc-T13 enhances cancer metastasis via a complex formation with integrin α5β1 and matrix metalloproteinase 9

Journal of Biological Chemistry

Volumn 288, Issue 33, 2013, Pages 24264-24276

  Matsumoto, Yasuyuki ^a   Zhang, Qing ^a   Akita, Kaoru ^b   Nakada, Hiroshi ^b   Hamamura, Kazunori ^a   Tsuchida, Akiko ^a,c   Okajima, Tetsuya ^a   Furukawa, Koichi ^a   Furukawa, Keiko ^a,d   Urano, Takeshi ^e  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KYOTO SANGYO UNIVERSITY   (Japan)

^c NOGUCHI INSTITUTE   (Japan)

^d CHUBU UNIVERSITY   (Japan)

^e SHIMANE UNIVERSITY FACULTY OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION; CELL CULTURE; PATHOLOGY;

CANCER METASTASIS; COMPLEX FORMATIONS; INTEGRINS; LUNG CANCER CELLS; MATRIX METALLOPROTEINASE-9; SYNDECAN-1;

DISEASES;

FIBRONECTIN; FOCAL ADHESION KINASE; GLYCOLIPID; METALLOPROTEINASE; METALLOPROTEINASE 9; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY MLS128; PAXILLIN; SYNDECAN 1; TN ANTIGEN; UNCLASSIFIED DRUG; VERY LATE ACTIVATION ANTIGEN 5;

ANTIGEN EXPRESSION; ARTICLE; CANCER CELL CULTURE; CELL ADHESION; CONTROLLED STUDY; ENHANCER REGION; GENE; GENE EXPRESSION; GENE IDENTIFICATION; METASTASIS; MOLECULAR MODEL; PPGALNAC T13 GENE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION;

MURINAE;

EID: 84882445310     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.455006     Document Type: Article

References (39)

1. Meng, X., Zhong, J., Liu, S., Murray, M., and Gonzalez-Angulo, A. M. (2012) A new hypothesis for the cancer mechanism. Cancer Metastasis Rev. 31, 247-268
2. Fuster, M. M., and Esko, J. D. (2005) The sweet and sour of cancer. Glycans as novel therapeutic targets. Nat. Rev. Cancer 5, 526-542
3. Kannagi, R. (2004) Molecular mechanism for cancer-associated induction of sialyl Lewis X and sialyl Lewis A expression. The Warburg effect revisited. Glycoconj. J. 20, 353-364
4. Li, M., Song, L., and Qin, X. (2010) Glycan changes. Cancer metastasis and anti-cancer vaccines. J. Biosci. 35, 665-673
5. Ju, T., Otto, V. I., and Cummings, R. D. (2011) The Tn antigen-structural simplicity and biological complexity. Angew. Chem. Int. Ed. Engl. 50, 1770-1791
6. Zhang, Q., Furukawa, K., Chen, H. H., Sakakibara, T., Urano, T., and Furukawa, K. (2006) Metastatic potential of mouse Lewis lung cancer cells is regulated via ganglioside GM1 by modulating the matrix metalloprotease-9 localization in lipid rafts. J. Biol. Chem. 281, 18145-18155
7. Matsumoto, Y., Zhang, Q., Akita, K., Nakada, H., Hamamura, K., Tokuda, N., Tsuchida, A., Matsubara, T., Hori, T., Okajima, T., Furukawa, K., Urano, T., and Furukawa, K. (2012) pp-GalNAc-T13 induces high metastatic potential of murine Lewis lung cancer by generating trimeric Tn antigen. Biochem. Biophys. Res. Commun. 419, 7-13
8. Numata, Y., Nakada, H., Fukui, S., Kitagawa, H., Ozaki, K., Inoue, M., Kawasaki, T., Funakoshi, I., and Yamashina, I. (1990) A monoclonal antibody directed to Tn antigen. Biochem. Biophys. Res. Commun. 170, 981-985
9. Mitsuda, T., Furukawa, K., Fukumoto, S., Miyazaki, H., Urano, T., and Furukawa, K. (2002) Overexpression of ganglioside GM1 results in the dispersion of platelet-derived growth factor receptor from glycolipid-enriched microdomains and in the suppression of cell growth signals. J. Biol. Chem. 277, 11239-11246
10. Beauvais, D. M., and Rapraeger, A. C. (2010) Syndecan 1 couples the insulin-like growth factor-1 receptor to inside-out integrin activation. J. Cell Sci. 123, 3796-3807
11. Morgan, M. R., Humphries, M. J., and Bass, M. D. (2007) Synergistic control of cell adhesion by integrins and syndecans. Nat. Rev. Mol. Cell Biol. 8, 957-969
12. Hynes, R. O. (2002) Integrins. Bidirectional, allosteric signaling machines. Cell 110, 673-687
13. Mitra, S. K., Hanson, D. A., and Schlaepfer, D. D. (2005) Focal adhesion kinase. In command and control of cell motility. Nat. Rev. Mol. Cell Biol. 6, 56-68
14. Clark, E. A., and Brugge, J. S. (1995) Integrins and signal transduction pathways. The road taken. Science 268, 233-239
15. Tarp, M. A., and Clausen, H. (2008) Mucin-type O-glycosylation and its potential use in drug and vaccine development. Biochim. Biophys. Acta 1780, 546-563
16. Brockhausen, I. (1999) Pathways of O-glycan biosynthesis in cancer cells. Biochim. Biophys. Acta 1473, 67-95
17. Wu, Y. M., Liu, C. H., Hu, R. H., Huang, M. J., Lee, J. J., Chen, C. H., Huang, J., Lai, H. S., Lee, P. H., Hsu, W. M., Huang, H. C., and Huang, M. C. (2011) Mucin glycosylating enzyme GALNT2 regulates the malignant character of hepatocellular carcinoma by modifying the EGF receptor. Cancer Res. 71, 7270-7279
18. Taniuchi, K., Cerny, R. L., Tanouchi, A., Kohno, K., Kotani, N., Honke, K., Saibara, T., and Hollingsworth, M. A. (2011) Overexpression of GalNActransferase GalNAc-T3 promotes pancreatic cancer cell growth. Oncogene 30, 4843-4854
19. Park, J. H., Nishidate, T., Kijima, K., Ohashi, T., Takegawa, K., Fujikane, T., Hirata, K., Nakamura, Y., and Katagiri, T. (2010) Critical roles of mucin 1 glycosylation by transactivated polypeptide N- acetylgalactosaminyltransferase 6 in mammary carcinogenesis. Cancer Res. 70, 2759-2769
20. Morita, N., Yajima, Y., Asanuma, H., Nakada, H., and Fujita-Yamaguchi, Y. (2009) Inhibition of cancer cell growth by anti-Tn monoclonal antibody MLS128. Biosci. Trends 3, 32-37
21. Tian, E., and Ten Hagen, K. G. (2009) Recent insights into the biological roles of mucin-type O-glycosylation. Glycoconj. J. 26, 325-334
22. Bennett, E. P., Mandel, U., Clausen, H., Gerken, T. A., Fritz, T. A., and Tabak, L. A. (2012) Control of mucin-type O-glycosylation. A classification of the polypeptide GalNAc-transferase gene family. Glycobiology 22, 736-756
23. Zhang, Y., Iwasaki, H., Wang, H., Kudo, T., Kalka, T. B., Hennet, T., Kubota, T., Cheng, L., Inaba, N., Gotoh, M., Togayachi, A., Guo, J., Hisatomi, H., Nakajima, K., Nishihara, S., Nakamura, M., Marth, J. D., and Narimatsu, H. (2003) Cloning and characterization of a new human UDPN-acetyl-D-galactosamine: polypeptide N-acetylgalactosaminyltransferase, designated pp-GalNAc-T13, that is specifically expressed in neurons and synthesizes GalNAc-serine/threonine antigen. J. Biol. Chem. 278, 573-584
24. Berois, N., Blanc, E., Ripoche, H., Mergui, X., Trajtenberg, F., Cantais, S., Barrois, M., Dessen, P., KAgedal, B., Bénard, J., Osinaga, E., and Raguénez, G. (2006) ppGalNAc-T13. A new molecular marker of bone marrow involvement in neuroblastoma. Clin. Chem. 52, 1701-1712
25. Giancotti, F. G., and Mainiero, F. (1994) Integrin-mediated adhesion and signaling in tumorigenesis. Biochim. Biophys. Acta 1198, 47-64
26. Chen, Q., Kinch, M. S., Lin, T. H., Burridge, K., and Juliano, R. L. (1994) Integrin-mediated cell adhesion activates mitogen-activated protein kinases. J. Biol. Chem. 269, 26602-26605
27. Xian, X., Gopal, S., and Couchman, J. R. (2010) Syndecans as receptors and organizers of the extracellular matrix. Cell Tissue Res. 339, 31-46
28. McQuade, K. J., and Rapraeger, A. C. (2003) Syndecan 1 transmembrane and extracellular domains have unique and distinct roles in cell spreading. J. Biol. Chem. 278, 46607-46615
29. Langford, J. K., Yang, Y., Kieber-Emmons, T., and Sanderson, R. D. (2005) Identification of an invasion regulatory domain within the core protein of syndecan-1. J. Biol. Chem. 280, 3467-3473
30. Beauvais, D. M., Ell, B. J., McWhorter, A. R., and Rapraeger, A. C. (2009) Syndecan 1 regulatesαvβ3 andαvβ5 integrin activation during angiogenesis and is blocked by synstatin, a novel peptide inhibitor. J. Exp. Med. 206, 691-705
31. Brown, M. C., and Turner, C. E. (2004) Paxillin. Adapting to change. Physiol. Rev. 84, 1315-1339
32. Deepa, S. S., Yamada, S., Zako, M., Goldberger, O., Sugahara, K. (2004) Chondroitin sulfate chains on syndecan-1 and syndecan-4 from normal murine mammary gland epithelial cells are structurally and functionally distinct and cooperate with heparan sulfate chains to bind growth factors. A novel function to control binding of midkine, pleiotrophin, and basic fibroblast growth factor. J. Biol. Chem. 279, 37368-37376
33. Munesue, S., Yoshitomi, Y., Kusano, Y., Koyama, Y., Nishiyama, A., Nakanishi, H., Miyazaki, K., Ishimaru, T., Miyaura, S., Okayama, M., Oguri, K. (2007) A novel function of syndecan-2, suppression of matrix metalloproteinase-2 activation, which causes suppression of metastasis. J. Biol. Chem. 282, 28164-28174
34. Mizumoto, S., Takahashi, J., Sugahara, K. (2012) Receptor for advanced glycation end products (RAGE) functions as receptor for specific sulfated glycosaminoglycans, and anti-RAGE antibody or sulfated glycosaminoglycans delivered in vivo inhibit pulmonary metastasis of tumor cells. J. Biol. Chem. 287, 18985-18994
35. Hakomori, S. I. (2010) Glycosynaptic microdomains controlling tumor cell phenotype through alteration of cell growth, adhesion, and motility. FEBS Lett. 584, 1901-1906
36. Inokuchi, J. (2010) Membrane microdomains and insulin resistance. FEBS Lett. 584, 1864-1871
37. Dong, Y., Ikeda, K., Hamamura, K., Zhang, Q., Kondo, Y., Matsumoto, Y., Ohmi, Y., Yamauchi, Y., Furukawa, K., Taguchi, R., and Furukawa, K. (2010) GM1 / GD1b / GA1 synthase expression results in the reduced cancer phenotypes with modulation of composition and raft-localization of gangliosides in a melanoma cell line. Cancer Sci. 101, 2039-2047
38. Musselli, C., Ragupathi, G., Gilewski, T., Panageas, K. S., Spinat, Y., and Livingston, P. O. (2002) Reevaluation of the cellular immune response in breast cancer patients vaccinated with MUC1. Int. J. Cancer 97, 660-667
39. Noujaim, A. A., Schultes, B. C., Baum, R. P., and Madiyalakan, R. (2001) Induction of CA125-specific B and T cell responses in patients injected with MAb-B43.13. Evidence for antibody-mediated antigen-processing and presentation of CA125 in vivo. Cancer Biother. Radiopharm. 16, 187-203